KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Return on Sales (2017 - 2025)

Historic Return on Sales for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to 0.35%.

  • Guardant Health's Return on Sales rose 2100.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 3000.0%. This contributed to the annual value of 0.59% for FY2024, which is 2600.0% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Return on Sales is 0.35%, which was up 2100.0% from 0.43% recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Return on Sales peaked at 0.35% during Q3 2025, and registered a low of 2.1% during Q2 2022.
  • Its 5-year average for Return on Sales is 0.9%, with a median of 0.68% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -10400bps in 2022, then surged by 15700bps in 2023.
  • Over the past 5 years, Guardant Health's Return on Sales (Quarter) stood at 0.67% in 2021, then tumbled by -65bps to 1.1% in 2022, then dropped by -9bps to 1.21% in 2023, then soared by 54bps to 0.55% in 2024, then skyrocketed by 36bps to 0.35% in 2025.
  • Its last three reported values are 0.35% in Q3 2025, 0.43% for Q2 2025, and 0.47% during Q1 2025.